REVIEW

Diagnostic potential of cell-free DNA as a liquid biopsy marker

About authors

1 Laboratory of Pharmacogenomics,
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia

2 Novosibirsk State University, Novosibirsk, Russia

Correspondence should be addressed: Maxim L. Filipenko
Prospekt Akademika Lavrentieva, d. 8, Novosibirsk, Russia, 630090; ur.csn.hcobin@xam

About paper

Funding: this review was supported by the state-funded project for basic research (2017-2020) Development of methods of personalized medicine (VI.62.2.2, 0309-2016-0007).

Received: 2017-08-25 Accepted: 2017-08-30 Published online: 2017-10-29
|
Fig. 1. The blood plasma of a pregnant woman contains fetal cfDNA that can be used in non-invasive prenatal testing for aneuploidies or monogenic diseases
Fig. 2. Key applications of liquid biopsy and cfDNA analysis in oncology